I believe CSL should buy back more shares given the depressed market conditions of entire biotech sector. It should have that financial capability. Given that it is on cost cutting drive, more large scale acquisitions are unlikely to occur, and with potentially lower cash needs going forward I guess more buyback make sense.
Add to My Watchlist
What is My Watchlist?